J&J 2nd-Q profit down 3.5% due to low Rx, weak dollar

Health care products maker J&J said its 2nd-Q profit fell 3.5% due to lower sales, particularly for its Rx drugs, & weak dollar. Still, the world's most broadly based health care company handily beat Wall Street expectations, partly due to cost controls. The New Brunswick-based maker of baby shampoo, contraceptives & biotech drugs earned $3.21B or $1.15 a share. That's down from $3.33B or $1.17 a share in